GlassScriptPhysician profile
Medel A Reyes
NPI 1598761215
$7,974.39
in general payments reported to CMS, 2019-2025
43 companies · $1,365 in 2025
The $1,365 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,295 · 2020: $450 · 2021: $795 · 2022: $980 · 2023: $1,052 · 2024: $1,036 · 2025: $1,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,453.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,789.35 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Jazz Pharmaceuticals INC. | $990.04 | 2019-2025 | |
| Pulmonx Corporation | $897.72 | 2019-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $703.29 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Insmed, INC. | $662.00 | 2019-2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $542.44 | 2019-2025 | Ofev, Jascayd |
| Genzyme Corporation | $318.19 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $187.30 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $155.09 | 2020-2025 | Prolastin-C Liquid |
| Intuitive Surgical, INC. | $153.68 | 2020-2023 | Da Vinci Surgical System |
| Abbott Laboratories | $139.87 | 2022 | |
| Edwards Lifesciences Corporation | $137.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $135.92 | 2019 | |
| Csa Medical, INC | $133.57 | 2019 | |
| Boston Scientific Corporation | $113.70 | 2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Medel Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.